2004 Bench-to-Bedside Funded Projects
|Project||Institute or institution/Investigators|
|Neural substrates underlying motor control of a newly implanted hand transplant||NIAMS: Cendales; L
NINDS: Cohen, Leonardo
|Development of Non-invasive treatment for uterine leiomyoma (fibroids)||NIEHS: Davis, B.
NICHD: Stratton, Pam CC: Partners
|Infrared and Near Infrared Image Guided Minimally Invasive Assessment of Renal Perfusion during Donor Nephrectomies and Partial Nephrectomies||NIDDK: Elster, E.; Kirk, Allan
NCI: Partners ORS: Partners
|Novel Approach for treatment of squamous cell malignancies with 17-AAG and bortezomib||NCI: Gius, D.; Neckers, Len
NIDCD: Van Waes, Carter
|Therapeutic application of intravascular nitrite for sickle cell disease||CC: Gladwin, M
NHLBI: Cannon, Richard
|Intermediate phenotype and genetic mechanisms for psychosis and cognitive disturbance in 22q11.2-hemideletion syndrome||
NCI: Meyer-Lindenberg, A.
|Molecular profiling of response to proteasome inhibition by bortezomib (PS341) in a clinical trial of mantle cell lymphoma||NHLBI: Weistner, Adrian
NCI: Wilson, Wyndham
|A Phase I/II pilot study to evaluate the treatment of intraocular lymphoma with BL22 immunotoxin||NEI: Nussenblatt, Robert
NCI: Pastan, Ira
|Immunotherapy for Myelodysplastic Syndrome||NHLBI: Barrett, John
NIAID: Douek, Daniel NCI: Rosenberg, Steve
|A Phase I Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)||NHGRI: Smith, Ann
CC: Grimes, George
|Pre-clinical non-human primate studies of an invo selectable vector intended for use in a planned clinical trial of gene therapy for chronic granulomatous disease||NIAID: Malech, Harry
NHLBI: Dunbar, Cynthia
|solation and Characterization of Circulating Endothelial Cells in Primary Pulmonary Hypertension: Implications for Early Diagnosis and Novel Therapeutic Targets||CC: Solomon, Michael; Danner, Robert
|Evaluation of the anti-IL-2/IL-15Rb monoclonal antibody Hu MiK-b-1 in a therapeutic trial in patients with HAM/TSP and a test of hypotheses concerning the role of IL-15 in the maintenance of CD8+ memory T-cells and in the pathogenesis of HAM/TSP||NINDS: Jacobson, Steven
NCI: Waldmann, Thomas
CC: Fleisher, Thomas
|Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development||NCI: Fox, E.
NHGRI: Baird, K.
|Molecular profiling and drug discovery for patients with PTEN Hamartomatous Tumor Syndromes (PHTS)||NCI: Dennis, P.
NHGRI: Elkahoun, A.
|Assessing the safety and immunogenicity of a therapeutic vaccination strategy using a DNA plasmid vaccine prime and a recombinant adenovector boost in HIV infected adults||NIAID: Graham, Barney
|Targeting vascular endothelial growth factor-A (VEGF-A) and receptor-2 (VEGFR-2) for the treatment of Primary Effusion Lymphoma||NCI: Tosato, Giovanna; Yarchoan, Robert
|Pediatric NeuroAIDS in the HAART Era: Identification of Disease Markers and Therapeutic Targets||NCI: Hazra, R.
NINDS: Major, Eugene; Schwartz, L.
|Treatment of Primary-Effusion Lymphoma with Combination Virolytic and Cytotoxic Chemotherapy||NCI: Yarchoan, Robert; Little, Richard
NIAID: Cohen, Jeffrey
Previous Awards Funded
NOTE: PDF documents require the free Adobe Reader.
This page last updated on 06/12/2017